| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
100,490,000 |
| Market
Cap: |
7.40(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$9.24 - $94.5 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Viking Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapies for metabolic and endocrine disorders. Co.'s primary clinical program's drug candidate, VK2809, is an orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRss). Co. is also developing VK0214, which is also an orally available, tissue and receptor-subtype selective agonist of TRss for X-linked adrenoleukodystrophy, a rare X-linked, inherited neurological disorder characterized by a breakdown in the protective barriers surrounding brain and nerve cells.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
348,181 |
852,260 |
908,260 |
1,615,026 |
| Total Sell Value |
$27,122,482 |
$40,299,016 |
$41,683,016 |
$54,614,939 |
| Total People Sold |
2 |
4 |
6 |
6 |
| Total Sell Transactions |
2 |
9 |
11 |
23 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lian Brian |
President & CEO |
• • – |
2023-04-13 |
4 |
OE |
$1.88 |
$102,152 |
D/D |
54,336 |
2,387,299 |
|
- |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2023-04-12 |
4 |
AS |
$18.00 |
$747,792 |
D/D |
(41,544) |
149,279 |
|
-20% |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2023-04-12 |
4 |
OE |
$5.80 |
$249,026 |
D/D |
41,544 |
190,823 |
|
- |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2023-04-11 |
4 |
AS |
$18.00 |
$1,013,518 |
D/D |
(56,295) |
149,279 |
|
-21% |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2023-04-11 |
4 |
OE |
$4.68 |
$295,778 |
D/D |
56,295 |
205,574 |
|
- |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2023-03-29 |
4 |
AS |
$16.00 |
$659,872 |
D/D |
(41,242) |
261,895 |
|
-11% |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2023-03-29 |
4 |
OE |
$9.13 |
$136,950 |
D/D |
15,000 |
303,137 |
|
- |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2023-03-28 |
4 |
AS |
$15.00 |
$2,948,445 |
D/D |
(196,563) |
288,137 |
|
-18% |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2023-03-28 |
4 |
OE |
$1.04 |
$397,193 |
D/D |
167,427 |
484,700 |
|
- |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2023-01-15 |
4 |
D |
$8.95 |
$9,657 |
D/D |
(1,079) |
317,273 |
|
- |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2023-01-04 |
4 |
D |
$8.42 |
$174,361 |
D/D |
(20,708) |
185,057 |
|
- |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2023-01-04 |
4 |
D |
$8.42 |
$117,829 |
D/D |
(13,994) |
318,352 |
|
- |
|
| Lian Brian |
President & CEO |
• • – |
2023-01-04 |
4 |
D |
$8.42 |
$240,972 |
D/D |
(28,619) |
2,272,963 |
|
- |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2023-01-03 |
4 |
D |
$8.52 |
$203,909 |
D/D |
(23,933) |
205,765 |
|
- |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
90,667 |
229,698 |
|
- |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2023-01-03 |
4 |
D |
$8.52 |
$160,636 |
D/D |
(18,854) |
332,346 |
|
- |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
90,667 |
351,200 |
|
- |
|
| Lian Brian |
President & CEO |
• • – |
2023-01-03 |
4 |
D |
$8.52 |
$581,507 |
D/D |
(68,252) |
2,301,582 |
|
- |
|
| Lian Brian |
President & CEO |
• • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
266,667 |
2,369,834 |
|
- |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2022-12-30 |
4 |
D |
$9.40 |
$185,152 |
D/D |
(19,697) |
139,031 |
|
- |
|
| Zante Greg |
Chief Financial Officer |
• – – |
2022-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
20,233 |
158,728 |
|
- |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2022-12-30 |
4 |
D |
$9.40 |
$120,066 |
D/D |
(12,773) |
260,533 |
|
- |
|
| Mancini Marianna |
Chief Operating Officer |
• – – |
2022-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
23,500 |
273,306 |
|
- |
|
| Lian Brian |
President & CEO |
• • – |
2022-12-30 |
4 |
D |
$9.40 |
$621,594 |
D/D |
(66,127) |
2,103,167 |
|
- |
|
| Lian Brian |
President & CEO |
• • – |
2022-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
121,667 |
2,169,294 |
|
- |
|
162 Records found
|
|
Page 3 of 7 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
6.56 (8.18%) 
